Dietary Quercetin Intake and Risk of Gastric Cancer: Results from a Population-based Study in Sweden

Overview

Journal Ann Oncol

Publisher Elsevier

Specialty Oncology

Date 2010 Aug 7

PMID 20688844

Citations 46

Authors

A M Ekstrom

M Serafini

O Nyren

A Wolk

C Bosetti

R Bellocco

Affiliations

Soon will be listed here.

Abstract

Background: To study the impact of the dietary antioxidant quercetin on risk of gastric adenocarcinoma.

Patients And Methods: Using data from a large Swedish population-based case-control study of gastric cancer (505 cases and 1116 controls), we studied the association between quercetin and risk of anatomic (cardia/noncardia) and histological (intestinal and diffuse) subtypes of gastric cancer.

Results: We found strong inverse associations between quercetin and the risk of noncardia gastric adenocarcinoma, with an adjusted odds ratio (OR) of 0.57 (95% confidence interval 0.40-0.83) for the highest quintile (≥11.9 mg) of daily quercetin intake relative to the lowest quintile of intake (<4 mg quercetin/day), supported by a significant decreasing linear trend (P value < 0.001). Similar findings were observed for the intestinal and diffuse subtype. For cardia cancer, we found a less evident and nonsignificant inverse relationship. The protection of quercetin appeared to be stronger among female smokers, with the OR leveled of at values <0.2 in quintiles 3-5 (>6 mg quercetin/day).

Conclusions: High dietary quercetin intake is inversely related to the risk of noncardia gastric adenocarcinoma, and the protection appears to be particularly strong for women exposed to oxidative stress, such as tobacco smoking.

Citing Articles

Weiwei Decoction alleviates gastric intestinal metaplasia through the olfactomedin 4/nucleotide-binding oligomerization domain 1/caudal-type homeobox gene 2 signaling pathway.

Zhou D, Zhang W, Song S, Hong X, Yang W, Li J World J Gastrointest Oncol. 2024; 16(7):3211-3229.

PMID: 39072182 PMC: 11271767. DOI: 10.4251/wjgo.v16.i7.3211.

Network pharmacology- and molecular docking-based exploration of the molecular mechanism underlying Jianpi Yiwei Recipe treatment of gastric cancer.

Chen P, Wu H World J Gastrointest Oncol. 2024; 16(7):2988-2998.

PMID: 39072163 PMC: 11271781. DOI: 10.4251/wjgo.v16.i7.2988.

Nanotechnology-based delivery systems to overcome drug resistance in cancer.

Patel H, Li J, Bo L, Mehta R, Ashby Jr C, Wang S Med Rev (2021). 2024; 4(1):5-30.

PMID: 38515777 PMC: 10954245. DOI: 10.1515/mr-2023-0058.

Hydroxyl Group Acetylation of Quercetin Enhances Intracellular Absorption and Persistence to Upregulate Anticancer Activity in HepG2 Cells.

Sakao K, Saruwatari H, Minami S, Hou D Int J Mol Sci. 2023; 24(23).

PMID: 38068974 PMC: 10706045. DOI: 10.3390/ijms242316652.

Pulmonary delivery of mucus-traversing PF127-modified silk fibroin nanoparticles loading with quercetin for lung cancer therapy.

Tang Y, Zhang L, Sun R, Luo B, Zhou Y, Zhang Y Asian J Pharm Sci. 2023; 18(4):100833.

PMID: 37635802 PMC: 10450418. DOI: 10.1016/j.ajps.2023.100833.

References

Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M . Helicobacter pylori infection and the development of gastric cancer. N Engl J Med. 2001; 345(11):784-9. DOI: 10.1056/NEJMoa001999. View

Czernichow S, Galan P, Hercberg S . Antioxidant supplements for prevention of gastrointestinal cancers. Lancet. 2005; 365(9458):470-1. DOI: 10.1016/S0140-6736(05)17857-X. View

Guruge J, Schalen C, Nilsson I, Ljungh A, Tyszkiewicz T, WIKANDER M . Detection of antibodies to Helicobacter pylori cell surface antigens. Scand J Infect Dis. 1990; 22(4):457-65. DOI: 10.3109/00365549009027078. View

Garcia-Closas R, Gonzalez C, Agudo A, Riboli E . Intake of specific carotenoids and flavonoids and the risk of gastric cancer in Spain. Cancer Causes Control. 1999; 10(1):71-5. DOI: 10.1023/a:1008867108960. View

Marchildon P, Ciota L, Zamaniyan F, Peacock J, Graham D . Evaluation of three commercial enzyme immunoassays compared with the 13C urea breath test for detection of Helicobacter pylori infection. J Clin Microbiol. 1996; 34(5):1147-52. PMC: 228971. DOI: 10.1128/jcm.34.5.1147-1152.1996. View

Evans Jr D, Evans D, Graham D, KLEIN P . A sensitive and specific serologic test for detection of Campylobacter pylori infection. Gastroenterology. 1989; 96(4):1004-8. DOI: 10.1016/0016-5085(89)91616-8. View

Scalbert A, Manach C, Morand C, Remesy C, Jimenez L . Dietary polyphenols and the prevention of diseases. Crit Rev Food Sci Nutr. 2005; 45(4):287-306. DOI: 10.1080/1040869059096. View

Vivekananthan D, Penn M, Sapp S, Hsu A, Topol E . Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials. Lancet. 2003; 361(9374):2017-23. DOI: 10.1016/S0140-6736(03)13637-9. View

Ekstrom A, Held M, Hansson L, Engstrand L, Nyren O . Helicobacter pylori in gastric cancer established by CagA immunoblot as a marker of past infection. Gastroenterology. 2001; 121(4):784-91. DOI: 10.1053/gast.2001.27999. View

10.

MISUMI A, Murakami A, Harada K, Baba K, Akagi M . Definition of carcinoma of the gastric cardia. Langenbecks Arch Chir. 1989; 374(4):221-6. DOI: 10.1007/BF01359557. View

11.

Hansson L, Sparen P, Nyren O . Survival in stomach cancer is improving: results of a nationwide population-based Swedish study. Ann Surg. 1999; 230(2):162-9. PMC: 1420858. DOI: 10.1097/00000658-199908000-00005. View

12.

Parkin D, Bray F, Ferlay J, Pisani P . Estimating the world cancer burden: Globocan 2000. Int J Cancer. 2001; 94(2):153-6. DOI: 10.1002/ijc.1440. View

13.

Serafini M, Bellocco R, Wolk A, Ekstrom A . Total antioxidant potential of fruit and vegetables and risk of gastric cancer. Gastroenterology. 2002; 123(4):985-91. DOI: 10.1053/gast.2002.35957. View

14.

Kim D, Lee C . Comprehensive study on vitamin C equivalent antioxidant capacity (VCEAC) of various polyphenolics in scavenging a free radical and its structural relationship. Crit Rev Food Sci Nutr. 2004; 44(4):253-73. DOI: 10.1080/10408690490464960. View

15.

Yang C, Landau J, Huang M, Newmark H . Inhibition of carcinogenesis by dietary polyphenolic compounds. Annu Rev Nutr. 2001; 21:381-406. DOI: 10.1146/annurev.nutr.21.1.381. View

16.

Block G, Jensen C, Morrow J, Holland N, Norkus E, Milne G . The effect of vitamins C and E on biomarkers of oxidative stress depends on baseline level. Free Radic Biol Med. 2008; 45(4):377-84. PMC: 2750000. DOI: 10.1016/j.freeradbiomed.2008.04.005. View

17.

Rice-Evans C, Miller N, Paganga G . Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Radic Biol Med. 1996; 20(7):933-56. DOI: 10.1016/0891-5849(95)02227-9. View

18.

Hansson L, Nyren O, Bergstrom R, Wolk A, Lindgren A, Baron J . Nutrients and gastric cancer risk. A population-based case-control study in Sweden. Int J Cancer. 1994; 57(5):638-44. DOI: 10.1002/ijc.2910570505. View

19.

Goldbohm R, Hertog M, Brants H, van Poppel G, van den Brandt P . Consumption of black tea and cancer risk: a prospective cohort study. J Natl Cancer Inst. 1996; 88(2):93-100. DOI: 10.1093/jnci/88.2.93. View

20.

Sugarbaker P, Yonemura Y . Clinical pathway for the management of resectable gastric cancer with peritoneal seeding: best palliation with a ray of hope for cure. Oncology. 2000; 58(2):96-107. DOI: 10.1159/000012086. View